VGK - ETF AI Analysis
Top Page
Vanguard FTSE Europe ETF (VGK)
Rating:61Neutral
Price Target:―
Positive Factors
Strong Overall Performance
The ETF has shown steady gains over the year and in recent months, indicating solid recent momentum.
Leading European Companies in Top Holdings
Several major European stocks in the top positions, including a strongly performing semiconductor company and solid financial and healthcare names, have helped support the fund’s returns.
Low Expense Ratio
The fund’s very low annual fee means more of the investment gains stay in investors’ pockets compared with higher-cost ETFs.
Negative Factors
Exposure to Underperforming Healthcare Stock
One of the larger healthcare holdings has been weak this year, which slightly drags on the fund’s overall performance.
Concentration in a Single Strong Tech Holding
The biggest position is a strongly performing semiconductor stock, so a downturn in that company or industry could have an outsized impact on the ETF.
Heavy Focus on European Markets
Because the ETF is concentrated in European countries with only a small U.S. allocation, investors are more exposed to economic and market swings in Europe.
VGK vs. SPDR S&P 500 ETF (SPY)
AUM29.78B
RegionEurope
Expense Ratio0.06%
Beta0.73
IssuerVanguard
Inception DateMar 04, 2005
Dividend Yield2.89%
Asset ClassEquity
Index TrackedFTSE Developed Europe All Cap
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,894,514
30 Day Avg. Volume2,703,748
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
100.14Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1181
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VGK Summary
VGK is the Vanguard FTSE Europe ETF, which follows the FTSE Developed Europe All Cap Index. It invests in a wide range of European companies across many countries and industries, giving you broad international diversification in one fund. Well-known holdings include Nestlé and HSBC, along with major healthcare, industrial, and energy firms. Someone might invest in VGK to spread their money beyond the U.S. market and tap into the long-term growth potential of European businesses. A key risk is that European stock prices can rise or fall with global markets and regional economic or political events.
How much will it cost me?The Vanguard FTSE Europe ETF (VGK) has an expense ratio of 0.06%, meaning you’ll pay $0.60 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, which typically costs less than actively managed funds.
What would affect this ETF?VGK could benefit from economic recovery in Europe, increased demand for healthcare and technology innovations, and strong performance from top holdings like ASML and SAP. However, it may face challenges from rising interest rates, geopolitical tensions, or sector-specific risks in financials and energy, which are significant parts of its portfolio.
VGK Top 10 Holdings
VGK leans heavily on Europe’s blue-chip leaders, with ASML acting as the main engine thanks to its strong, rising momentum over the past few months. Financial giants like HSBC and Allianz are also pulling their weight, giving the fund a solid banking and insurance backbone, while Banco Santander adds a more mixed but generally supportive tilt. On the defensive side, health care names such as Novartis and Roche are steady contributors, even as AstraZeneca and Nestlé feel a bit sluggish. Overall, it’s a diversified bet on developed Europe, not a single-country or single-theme story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 4.79% | $1.84B | €597.04B | 127.48% | 76 Outperform | |
| HSBC Holdings | 2.04% | $780.01M | £266.83B | 61.62% | 80 Outperform | |
| Novartis AG | 1.83% | $700.94M | CHF231.67B | 37.69% | 80 Outperform | |
| Roche Holding AG | 1.81% | $695.06M | $345.58B | 34.54% | 73 Outperform | |
| AstraZeneca | 1.76% | $673.16M | $261.19B | 19.44% | 80 Outperform | |
| Nestlé SA | 1.66% | $634.56M | CHF207.50B | 6.66% | 71 Outperform | |
| Siemens | 1.48% | $567.07M | €207.53B | 21.64% | 74 Outperform | |
| Banco Santander | 1.26% | $482.67M | €175.79B | 59.08% | 73 Outperform | |
| Shell (UK) | 1.25% | $478.02M | £183.16B | 21.96% | 73 Outperform | |
| Allianz | 1.13% | $433.19M | €161.74B | 25.58% | 67 Neutral |
VGK Technical Analysis
Positive
―
Price Trends
87.78
Positive
85.82
Positive
83.91
Positive
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VGK, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 88.56, equal to the 50-day MA of 87.78, and equal to the 200-day MA of 83.91, indicating a bullish trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VGK.
VGK Peer Comparison
Comparison Results
Performance Comparison
VGK
Vanguard FTSE Europe ETF
88.84
14.62
19.70%
EZU
iShares MSCI Eurozone ETF
―
―
―
BBEU
JPMorgan BetaBuilders Europe ETF
―
―
―
IEUR
iShares Core MSCI Europe ETF
―
―
―
HEDJ
WisdomTree Europe Hedged Equity Fund
―
―
―
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents